Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for HB0036 in adults with advanced solid tumors, including non-small cell lung cancer, focusing on safety and preliminary effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HB0036

Snippet

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor, NSCLC | Phase 1, Phase 2 | Status: RECRUITING